University of Cincinnati leads first trial on steroid and CNI withdrawal post ... Science Codex CINCINNATI—The University of Cincinnati will lead a $5.2 million national trial studying removal of both corticosteroids and common immunosuppression treatments from the post-transplant drug regimen for kidney transplant patients. The Belatacept Early ... |
